Concepedia

Natarajan Venkatesan

NV

Statistics

Publications

59

Citations

3.7K

H-Index

32

Active since

1968

Affiliations

University of California, Los Angeles(Current)

Cedars-Sinai Medical Center

Midwestern University

VA Greater Los Angeles Healthcare System

UCLA Jonsson Comprehensive Cancer Center

Natarajan Venkatesan is an author at University of California, Los Angeles specializing in pharmacology, medicine, and life sciences.

ORCID

Publications per year

1968–2020

59

Publications

59

Activity of the Dual Kinase Inhibitor Lapatinib (GW572016) against HER-2-Overexpressing and Trastuzumab-Treated Breast Cancer Cells

Gottfried E. Konecny, Mark D. Pegram, Natarajan Venkatesan et al. · Cancer Research · 2006 · 909 citations

, , +11

Glucose Transport Is Rate Limiting for Skeletal Muscle Glucose Metabolism in Normal and STZ-Induced Diabetic Rats

Frederick H. Ziel, Natarajan Venkatesan, Mayer B. Davidson · Diabetes · 1988 · 208 citations

, , +15

Liquid filled nanoparticles as a drug delivery tool for protein therapeutics

Natarajan Venkatesan, J. Yoshimitsu, Nobuhito Shibata et al. · Biomaterials · 2005 · 191 citations

, , +14

Anti-diarrhoeal potential of Asparagus racemosus wild root extracts in laboratory animals.

Natarajan Venkatesan, Vadivu Thiyagarajan, Sathiya Narayanan et al. · PubMed · 2005 · 124 citations

, , +15

Therapeutic Potential of the Poly(ADP-ribose) Polymerase Inhibitor Rucaparib for the Treatment of Sporadic Human Ovarian Cancer

Maike Ihnen, Christine zu Eulenburg, Teodora Kolarova et al. · Molecular Cancer Therapeutics · 2013 · 114 citations · Full text

, , +17

1–5 of 59